(Q49074970)

English

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.

scientific article published on 4 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

9

object named as

Tanuja Chitnis

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

Howard L. Weiner

10

object named as

Howard L Weiner

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Francisco J. Quintana

8

object named as

Francisco Quintana

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

author name string

Pia Kivisäkk

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Brian C Healy

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Katiana Francois

3

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Roopali Gandhi

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Taha Gholipour

5

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Svetlana Egorova

6

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Velina Sevdalinova

7

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Samia J Khoury

11

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

publication date

4 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

20

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

4

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

438-444

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Disease Biomarkers in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

A molecular trio in relapse and remission in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Plasma osteopontin levels in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

The role of osteopontin in tumor progression and metastasis in breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Osteopontin and mucosal protection

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Osteopontin expression and relation to disease severity in human asthma

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Osteopontin in cardiovascular disease: a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

In vitro and clinical studies examining the expression of osteopontin in cigarette smoke-exposed endothelial cells and cigarette smokers

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Natalizumab effects on immune cell responses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458513503052

21 January 2018

Identifiers

10.1177/1352458513503052

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/24005026

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49074970&oldid=1427281915"